Du är här

2016-02-02

Invitation: Actelion to discuss full year 2015 financial results

Actelion Pharmaceuticals Ltd / Invitation: Actelion to discuss full year 2015
financial results. Processed and transmitted by NASDAQ OMX Corporate
Solutions. The issuer is solely responsible for the content of this
announcement.
Dear member of the investment community

Actelion Ltd will announce its 2015 full year financial results on Tuesday, 9
February 2016, at 07.00 hrs CET / 06.00 hrs GMT / 01.00 a.m. EST.
An investor conference call&webcast will be held at 14.00 hrs, CET to discuss
the results.

To support your preparations, consensus estimates can be found
underwww.actelion.com/consensus-estimate

Date/Time
:

--------------------------------------------------------
| |
| 9 February 2016 14.00 hrs - 14.45 hrs Basel (CET) |
| 13.00 hrs - 13.45 hrs UK (GMT) |
| 8.00 a.m. - 8.45 a.m. US (EST) |
--------------------------------------------------------

Conference Call Connect #:

Dial-in participants should start calling the number below 10-15 minutes
before the conference is due to start.

---------------------------------------
| |
| Dial: Europe: +41 (0)44 583 18 01 |
| UK: +44 (0)203 194 05 61 |
| US: +1 646 722 48 98 |
| |
---------------------------------------
Participant's mode:
Listen-Only with possibility to open individual lines during Q&A session.
Participants will be asked for their Name and Company.

Webcast Access
:

Webcast participants should visit the Actelion
websitehttp://www.actelion.com10-15 minutes before the conference is due to
start.

Participant's mode: Listen-Only

Webcast Replay:

The archived Investor Webcast will be available for replay
throughhttp://www.actelion.com/ approximately 60 minutes after the call has
ended.

Invitation PDF
http://hugin.info/131801/R/1983095/726688.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Globenewswire

HUG#1983095

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.